Our purpose was to compare the effi cacy, complications, success rate, recurrence rate at 1 year, and crossovers of rubber band ligation (RBL) with those of bipolar electrocoagulation (BPEC) treatment for chronically bleeding internal hemorrhoids.
INTRODUCTION
Internal hemorrhoids are a common health problem that results in signifi cant morbidity and high economic cost for health care of patients. In 1994, the National Institutes of Health estimated that 10.4 million Americans suff er from hemorrhoids annually, prompting at least 3.5 million physician visits per year at an estimated cost of $ 500 million (1) . Internal hemorrhoids are the most common cause of recurrent hematochezia in ambulatory adults (1 -4) . Th ey are dilated venous plexuses located above the dentate line. As internal hemorrhoids enlarge, the increasing amount of redundant tissue leads to progressive hemorrhoid protrusion below the dentate line. Chronic venous engorgement may eventually lead to bleeding, pain, and other symptoms. Th e most common symptoms of internal hemorrhoids include rectal bleeding, protrusion, pain, itching, and soiling (5) .
For the majority of patients with grade I hemorrhoids and intermittent hemorrhoidal symptoms, medical therapy is appropriate and adequate (5) . Surgical hemorrhoidectomy is the most eff ective and rapid treatment for chronic, symptomatic grades III and IV internal hemorrhoids. However, it is associated with signifi cantly more pain and complications than non-operative techniques (6) . Accordingly, surgery is usually recommended in selected patients who fail medical and nonoperative therapy; have grade IV hemorrhoids, mixed internal and external hemorrhoids, or concomitant anorectal conditions 10.1038/ajg.2009.292 Randomized Prospective Study of Endoscopic Rubber Band Ligation Compared With Bipolar Coagulation for Chronically Bleeding Internal Hemorrhoids most amenable to surgery; as well as for those who choose surgery as their preferred treatment (7) . Approximately 10 -20 percent of patients with symptomatic internal hemorrhoids are currently being treated surgically (5, 6, 8) .
Th e development of anoscopic and endoscopic devices for the non-operative treatment of internal hemorrhoids allowed physicians, surgeons, and endoscopists to have a wider range of therapeutic options for their patients who failed medical management. Non-operative techniques for ablating hemorrhoids include sclerotherapy, rubber band ligation (RBL), infrared photocoagulation, direct current coagulation, bipolar electrocoagulation (BPEC), and heater probe thermocoagulation. Each of these non-operative therapies can be safely carried out on an outpatient basis. None of the therapies require conscious sedation, and complications are infrequent and usually minor. Endoscopic treatment is most appropriate for grades II and III internal hemorrhoids, but is also indicated when medical treatment of grade I hemorrhoids has failed (5) . Sclerotherapy is the oldest form of non-operative treatment. It is recommended as a treatment option for patients with grades I and II hemorrhoidal disease. Th is technique causes thrombosis of vessels, sclerosis of connective tissue, and shrinkage of the overlying mucosa. Pain is variably reported in 12 -70 % of patients (9 -11) . Severe complications, including erectile dysfunction and abscess formation, are rare but may occur (12 -15) .
Rubber band ligation is now more commonly used than sclerotherapy. Ligation causes focal ischemic necrosis, ulceration, and scarring, which results in fi xation of the connective tissue to the rectal wall. Earlier studies have shown that RBL is the most eff ective non-operative treatment with the fastest obliteration rate and the lowest recurrence rate (16 -20) . However, more discomfort was reported than with other techniques (21 -23) .
Bipolar electrocoagulation is one of the most eff ective coagulation techniques for internal hemorrhoid treatment (4, 24, 25) . It causes coagulation, occlusion, sclerosis, and fi brosis of the internal hemorrhoidal tissue. Th e procedure is fast and has relatively few complications, which are usually minor (4, 24, 25) . Several studies have compared BPEC with other types of coagulation. In randomized prospective trials comparing BPEC with direct current coagulation, the BPEC treatments were signifi cantly more comfortable, took less time, and resulted in fewer recurrences, but had more complications (4, 24) . In another randomized prospective comparative study of bipolar coagulation vs. heater probe, the techniques and complications of the two treatments were reported to be similar (25) . However, although bipolar coagulation caused less pain during the treatment than the heater probe, it also resulted in a greater number of treatment failures and required more treatment sessions for symptomatic relief (25) . In another randomized comparison of infrared coagulation with bipolar coagulation, there was no signifi cant diff erence in complications or number of treatments required to relieve internal hemorrhoidal symptoms, including bleeding (26) .
To our knowledge, there have been no earlier randomized studies reported that compare the relative risks and benefi ts of RBL vs. bipolar coagulation for the treatment of bleeding from internal hemorrhoids. Our purposes in this randomized prospective study were to assess whether RBL obliterated internal hemorrhoids more rapidly than bipolar coagulation, and whether RBL was as safe and well tolerated as bipolar coagulation for patients with chronic bleeding from internal hemorrhoids. Durability of treatments and recurrence of hemorrhoidal bleeding or other symptoms were also evaluated at 1 year.
METHODS

Specifi c aims, inclusion, and exclusion criteria
Th is randomized study of endoscopic RBL vs. anoscopic BPEC for internal hemorrhoids was carried out at the UCLA Medical Center and at the Greater Los Angeles VA Health Care System. Th is study was approved by IRB committees at each medical center. Th e specifi c aims of this study were: (i) to compare the effi cacy of endoscopic band ligation vs. BPEC for the treatment of patients with chronic bleeding from grades II and III internal hemorrhoids, (ii) to evaluate the safety and tolerability of the two diff erent treatments, and (iii) to evaluate the durability of treatment eff ect and recurrence of symptoms at 1 year. All patients enrolled into this study met all of the following inclusion criteria: (i) grade II or III internal hemorrhoids with chronic rectal bleeding, which failed at least 8 weeks of intensive medical therapy, (ii) age over 18 years, (iii) a life expectancy of at least 24 months, and (iv) a signed written informed consent.
Th e spectrum of internal hemorrhoid bleeding includes severe overt bleeding (bright red blood, with or without bowel movements or with exercise) with anemia, to moderate overt rectal bleeding, to only spotting red blood on toilet tissue or underclothes or passage of blood-tinged mucus. However, all patients randomized in this study had to have severe episodic rectal hemorrhage. Th e primary goal of the treatments was to eliminate all types of internal hemorrhoid bleeding.
Patients were excluded from the study if any one of the following were present: (i) the patient was uncooperative, unable to sign a written informed consent, or could not return for routine outpatient follow-up, (ii) severe or end-stage comorbid illness, including cirrhosis, portal hypertension, severe renal or respiratory failure, sepsis, active rectal infl ammatory bowel disease, and acquired immune defi ciency syndrome, (iii) earlier endoscopic (e.g., sclerotherapy, ligation, etc.) or surgical (e.g., hemorrhoidectomy) treatment of hemorrhoids within the past 6 months, (iv) ongoing need for anticoagulation therapy (with warfarin or heparin) or high doses of aspirin and / or non-steroidal anti-infl ammatory agents, (v) presence of severe rectal pain, (vi) only grade I or presence of grade IV internal hemorrhoids, (vii) recently thrombosed internal or external hemorrhoids, (viii) anal stricture, fi ssure, fi stula, or abscess, (ix) rectal carcinoma or bleeding distal colonic polyp, (x) rectal varices, (xi) acute or chronic colitis, (xii) rectal prolapse, (xiii) radiation telangiectasia of the rectum, (xiv) coagulopathy defi ned
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as a prothrombin time >3 s over control (INR (international normalized ratio) >1.3), or (xv) thrombocytopenia defi ned as a platelet count < 75,000.
All patients in this study had chronic rectal bleeding from grade II or III internal hemorrhoids documented by diagnostic sigmoidoscopy, or colonoscopy and anoscopy, and they had failed at least 8 weeks of intensive medical therapy with bulk agents (psyllium, Metamucil, or Citrucel), stool soft eners (Colace or Surfak), warm water sitz baths, topical creams and / or suppositories with low-dose corticosteroids. Internal hemorrhoid grade was assessed using a slotted anoscope before study enrollment and before all treatments in every patient.
Sample size estimate
A sample size estimate was made on the basis of our earlier experience with RBL and BPEC for the number of treatment sessions to completely control rectal bleeding. Th is was expected to be a mean of two treatment sessions for RBL vs. four sessions with BPEC. For 80 % power, an alpha of 0.05, and two-sided comparison, 14 patients per group were the estimated sample size. To obviate any problems with potential dropouts, inaccuracy of this estimate, and to insure adequate numbers of patients for the analyses of secondary outcomes, we sought to randomize approximately 45 patients, or 21 -24 patients per treatment group.
Data collection and analysis
Th e Data were collected by the investigators and a study coordinator on standard Center for Ulcer Research and Education: Digestive Diseases Research Center (CURE: DDRC) hemostasis study forms. Data were entered into computer fi les and SAS was used for data management and analyses.
Th e primary outcome compared between the two treatment groups was the number of treatment sessions required to: (i) relieve the bleeding and (ii) reduce all internal hemorrhoids to grade 0 or I. Secondary outcomes that were analyzed for the two treatments were: (i) treatment complications, and (ii) rate of recurrent bleeding or other internal hemorrhoidal symptoms within 12 months.
Th e mean and median numbers of sessions were compared between the two groups using t -tests and the non-parametric analog (Wilcoxon rank sum test). Secondary outcomes were compared using these same methods. Time to symptomatic internal hemorrhoid recurrence was examined over a 12-month post-obliteration follow-up period using survival (timeto-event) analysis methods and log-rank tests for comparing the two groups. Background variables, such as sex, age, hemorrhoid grade, and other demographics, were also compared to verify that the randomization was carried out successfully.
Assessment, randomization, and hemorrhoids treatment devices and techniques
All patients who were referred to investigators for evaluation of rectal bleeding (suspected to be from hemorrhoids by the referral physicians) underwent an initial sigmoidoscopy, or colonoscopy and anoscopy for evaluation of rectal bleeding (refer to Figure 1 ). Aft er patients met the inclusion and exclusion criteria and signed a written informed consent, the treatment was determined by opening a sealed envelope at the time of the slotted anoscopy, which randomized patients to one of two treatment groups: (i) endoscopic RBL, or (ii) BPEC. Before initiation of the study, a study notebook with sealed opaque envelopes containing cards designating the treatment were prepared for both centers. A computer-generated randomization schedule was used to make up these cards. Two very experienced hemostasis-attending physicians (Jensen DM and Jutabha R) assessed the grade of the hemorrhoids and carried out all the therapeutic endoscopies.
Patients randomized to endoscopic RBL were treated with a diagnostic video endoscope (Pentax 2900, Pentax Medical Co., Montvale, NJ) fi tted with a single-shot ligating device (Stiegmann-Goff Ligator -, C.R. Bard, Tewksbury, MA) or multi-shot device (Four-shooter, Cook Endoscopy, Winston-Salem, NC). Rubber band ligation was carried out with the endoscope in an end-on and / or retrofl exed position similar in technique to esophageal variceal ligation and junctional gastric variceal ligation. Th e majority of treatments were carried out using the single-shot device. A maximum of four internal hemorrhoids were banded у 1 cm above the dentate line during each session (see Figure 2 ). Treatments were repeated every 4 -6 weeks until relief of bleeding and reduction of all internal hemorrhoids to grade 0 or I.
Patients randomized to bipolar coagulation therapy (previous Circon ACMI, Stamford, CT; new manufacturer now CONMED, Utica, NY) had a maximum of four hemorrhoid segments treated у 1 cm above the dentate line using a rigid probe with 1 s pulses at a 16 watt setting (average of 6 -8 pulses per internal hemorrhoid segment) through a slotted anoscope (see Figure 3 ). Treatments were repeated at 4-to 6 -week intervals until relief of bleeding and reduction of all internal hemorrhoids to grade 0 or I.
Pain ratings, follow-up, and success / failure ratings Aft er each session, patients fi lled out a questionnaire form using a 10-cm visual analog scale to assess the level of pain associated with the treatment. Patients were instructed to continue intensive medical management with daily warm water sitz baths, stool soft eners, fi ber supplementation, and hydrocortisone-based creams (RBL) or hydrocortisone suppositories (bipolar group) as needed (for swelling, pressure, mild pain, or bleeding) during the fi rst week aft er these treatments. In our experience, for a week aft er RBL, pushing a suppository into the anus against the banded internal hemorrhoids may lead to worse pain. Hence, we recommended the cream in RBL patients, instead of suppositories. Patients were also advised to notify the research coordinator if they developed severe rectal pain, bleeding, fevers, or chills.
Study end points were control of all (both severe and on toilet tissue) rectal bleeding, a severe complication or refusal to continue the treatment, and reduction of all internal hemorrhoid COLON/SMALL BOWEL Jutabha et al.
segments to grade 0 or I in three or less treatment sessions. Th ese end points were monitored and independently recorded on study forms by a research study coordinator. She fi rst clarifi ed any questions with the patient, primary care physician, or endoscopist.
Aft er achieving the treatment end points, all patients were followed up by the gastroenterologist and / or study coordinator once every 3 months for a total of at least 12 months to assess the recurrence of internal hemorrhoidal symptoms and change in size of internal hemorrhoids. Symptomatic recurrences were treated medically, and if this failed, anoscopic re-treatment was carried out.
Treatment failures for this study were predefi ned as: (i) a major complication of treatment (e.g., severe rectal pain requiring analgesics or severe bleeding, i.e., fall in baseline hematocrit у 5 % ; anal stricture; or rectal abscess), or (ii) unresponsiveness to therapy, defi ned as failure to reduce all internal hemorrhoid segments to grade I or less aft er three treatment sessions. Patients who failed treatment were taken off the study and given the choice of either crossover and treatment with the other therapy (e.g., bipolar probe or RBL), or treatment with any current medical, endoscopic, or surgical therapies.
RESULTS
Baseline and initial results
From 1997 to May 2000, 100 patients with chronic rectal bleeding suspected to be from internal hemorrhoids by referral physicians were assessed for this study (refer to Figure 1 ). A total of 55 patients were excluded because they did not meet inclusion criteria ( n = 30), had exclusions ( n = 20), or refused to participate ( n = 5). A total of 45 patients of mean age 51.5 years, with bleeding grade II or III internal hemorrhoids, were enrolled into this prospective randomized trial comparing RBL (24 patients) vs. bipolar coagulation (21 patients). Background variables are shown in Table 1 . Th e two treatment groups were comparable with respect to age (53 ± 3 vs. 50 ± 3 years), gender (54 % vs. 71 % men), and duration of chronic, recurrent rectal bleeding before randomization (9 ± 2 vs. 8 ± 2 years) for RBL and bipolar coagulation, respectively. Hemorrhoid grade was somewhat more advanced in patients treated with bipolar coagulation (29 % grade II, 71 % grade III) than with RBL (42 % grade II, 56 % grade III), although these diff erences were not statistically signifi cant.
Th e patients in the RBL treatment group and bipolar coagulation treatment group had similar symptoms at the time they were randomized, as shown in Table 2 . All patients had recurrent rectal bleeding. Concomitant hemorrhoidal prolapse and rectal discomfort occurred in 41 -62 % of all patients. Perirectal itching and soiling were reported in 13 -33 % of patients.
Treatment results and follow-up
Rubber band ligation was more eff ective than bipolar coagulation in controlling bleeding and reducing the hemorrhoid size (92 % vs. 62 % , respectively, P < 0.05) within three treatment sessions (see Table 3 ). Furthermore, RBL required significantly fewer treatment sessions (2.3 ± 0.2 sessions) than bipolar coagulation therapy (3.8 ± 0.4 sessions) to control the bleeding ( P < 0.05).
Eight patients (38 % ) treated with bipolar coagulation failed to achieve the treatment end points within three sessions because of ongoing rectal bleeding or persistent hemorrhoidal prolapse (grade у II). All of these patients were crossed over to RBL, which controlled bleeding or prolapse aft er 1 -2 treatments. bipolar coagulation had moderately severe rectal pain, requiring oral narcotic analgesics, but not hospitalization ( P > 0.05). No one in either group had other severe complications such as perirectal abscess, anal fi ssure, or rectal stenosis. Mild complications were in similar frequency in both groups (4 % in RBL group, 5 % in bipolar group). Median pain scores collected from our questionnaire using a 10-cm visual analog scale were not diff erent between the two groups (see Table 4 ). Only during the second treatment session was the pain score higher in the RBL group than in the bipolar coagulation group.
Once the bleeding was controlled and the internal hemorrhoids were reduced to grade I or less in size, other symptoms (e.g., shown in Table 2 ) were also controlled. However, with internal hemorrhoid enlargement, bleeding, prolapse, and pain recurred more oft en than itching or soiling. Th e rate of recurrent internal hemorrhoid symptoms (rectal bleeding and / or hemorrhoidal prolapse) was low in both treatment groups. At a mean follow-up period of 50 weeks, the respective rates for RBL and bipolar probe pretreatment for recurrent internal hemorrhoidal symptoms or bleeding were 10 and 15 % . Th ese symptoms were easily controlled with 1 -2 repeat anoscopic treatments in all patients with recurrence.
DISCUSSION
Internal hemorrhoids are very common in adults and are the most frequent cause of self-limited hematochezia in ambulatory adults (1 -4) . Hemorrhoid bleeding may occur from any grade of internal hemorrhoids, but severe bleeding usually occurs from grade II, III, or IV hemorrhoids. When bleeding is chronic over several years, as in our study, most patients fail medical therapy and require either endoscopic or surgical therapy to control the bleeding. Th e patients in this study were representative of a subgroup with severe internal hemorrhoidal bleeding who did not respond to a minimum 8 weeks of intensive medical treatment. Th ey had grade II or III hemorrhoids and had suff ered from these internal hemorrhoids with recurrent symptoms for 6 to 11 years. By history, patients had received many courses of medical therapy without control of rectal bleeding and pain.
Th is is the fi rst randomized prospective study comparing RBL treatment with bipolar coagulation. We tested the hypothesis that RBL treatment would be superior to bipolar coagulation treatment for chronically bleeding, large internal hemorrhoids. Th e rationale for this hypothesis and study was that endoscopic RBL is reported to be easy, fast, and effi cient, particularly for control of severe bleeding (27 -29) . However, we expected higher rates of rectal pain and other complications with RBL, as these have been reported in the past (30 -32) . In earlier randomized trials, bipolar coagulation was also an eff ective technique, superior to direct current coagulation (4) . In addition, in another randomized study by our group, bipolar probe was less eff ective than heater probe for hemostasis of chronically bleeding internal hemorrhoids (25) . However, no earlier study has compared RBL with bipolar coagulation head to head. Successful treatment was defi ned as treatment resulting in control of hematochezia, decrease of all internal hemorrhoid segments to grade I or less, and the absence of severe complications within three treatment sessions. RBL was found to be more effi cacious than bipolar coagulation as supported by the fact that 92 % of patients who underwent RBL had successful treatment vs. 62 % of patients who had bipolar coagulation. Th e complete resolution of bleeding with RBL aft er crossover when bipolar coagulation failed helped confi rm the superiority of the RBL treatment effi cacy.
Th e signifi cantly fewer number of treatment sessions needed to control hemorrhoidal bleeding with RBL vs. bipolar coagulation (3.8 vs. 2.3, P < 0.05) supports our hypothesis that RBL treats symptomatic grades II and III internal hemorrhoids more rapidly and eff ectively than bipolar coagulation.
Aft er RBL, a few more patients had moderately severe posttreatment pain (8 % -2 patients) than bipolar pain (0 % ), but the diff erence was not statistically signifi cant. In addition, somewhat higher pain scores were reported with the second RBL treatment than with second bipolar treatment, but this was not signifi cant. Th ere was no statistically signifi cant diff erence in complication rates between the RBL group and the bipolar coagulation group. Th us, RBL was as safe and well tolerated as bipolar coagulation for treating patients with chronically bleeding internal hemorrhoids. Th is was contrary to what has been reported when RBL was compared with other treatments (30 -32) .
On the basis of these results, the overall effi cacy of RBL was signifi cantly higher than bipolar coagulation in patients with grades II and III chronically bleeding internal hemorrhoids. Given that both treatments were equally safe and well tolerated, RBL should be considered as the fi rst-line treatment of patients with grades II and III hemorrhoids that have failed medical management. Bipolar coagulation may be recommended for patients who have had pain or other complications of earlier RBL treatment and who are reluctant to have a repeat RBL treatment because of moderate or severe pain from earlier RBL. It should be emphasized that all patients in this study had relief of their symptoms as a result of medical therapy combined with RBL and / or bipolar coagulation.
Our conclusions from this study are: (i) RBL had a signifi cantly higher success rate and took fewer sessions than bipolar coagulation to relieve symptoms, (ii) Th e safety and complication rates were similar for RBL and bipolar coagulation, (iii) Th e recurrence rate of internal hemorrhoidal symptoms aft er 1 year was low in both the treatment groups, (iv) a few more patients had severe pain with RBL, but the diff erence was not signifi cant.
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